Autonomix Medical, Inc.
AMIX
$5.37
$0.101.90%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.26M | 1.28M | 1.62M | 5.17M | 1.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.77M | 2.74M | 3.34M | 7.53M | 3.42M |
| Operating Income | -2.77M | -2.74M | -3.34M | -7.53M | -3.42M |
| Income Before Tax | -2.73M | -2.67M | -3.26M | -7.45M | -3.34M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.73M | -2.67M | -3.26M | -7.45M | -3.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.73M | -2.67M | -3.26M | -7.45M | -3.34M |
| EBIT | -2.77M | -2.74M | -3.34M | -7.53M | -3.42M |
| EBITDA | -2.77M | -2.73M | -3.34M | -7.53M | -3.42M |
| EPS Basic | -5.02 | -4.93 | -7.65 | -28.91 | -22.69 |
| Normalized Basic EPS | -3.14 | -3.08 | -4.78 | -18.07 | -14.18 |
| EPS Diluted | -5.02 | -4.93 | -7.65 | -28.91 | -22.69 |
| Normalized Diluted EPS | -3.14 | -3.08 | -4.78 | -18.07 | -14.18 |
| Average Basic Shares Outstanding | 543.70K | 541.00K | 426.50K | 257.70K | 147.10K |
| Average Diluted Shares Outstanding | 543.70K | 541.00K | 426.50K | 257.70K | 147.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |